A Combination of Geniposide and Chlorogenic Acid Combination Ameliorates Nonalcoholic Steatohepatitis in Mice by Inhibiting Kupffer Cell Activation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Combination of Geniposide and Chlorogenic Acid Combination Ameliorates Nonalcoholic Steatohepatitis in Mice by Inhibiting Kupffer Cell Activation
Authors
Keywords
-
Journal
Biomed Research International
Volume 2021, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2021-05-16
DOI
10.1155/2021/6615881
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- High-trans fatty acid and high-sugar diets can cause mice with non-alcoholic steatohepatitis with liver fibrosis and potential pathogenesis
- (2020) Xin Xin et al. Nutrition & Metabolism
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography
- (2020) Toshifumi Tada et al. Journal of Medical Ultrasonics
- The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
- (2019) Jingjing Cai et al. HEPATOLOGY
- Resolving inflammation in nonalcoholic steatohepatitis
- (2019) Matthew Spite JOURNAL OF CLINICAL INVESTIGATION
- Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis
- (2018) Xiaoyu Wang et al. ANTIOXIDANTS & REDOX SIGNALING
- Animal models of NAFLD from a hepatologist's point of view
- (2018) Daniel Jahn et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
- (2018) Vignan Manne et al. Clinics in Liver Disease
- Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease
- (2018) Qian Liu et al. CURRENT PHARMACEUTICAL DESIGN
- The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Konstantin Kazankov et al. Nature Reviews Gastroenterology & Hepatology
- Geniposide and Chlorogenic Acid Combination Ameliorates Non-alcoholic Steatohepatitis Involving the Protection on the Gut Barrier Function in Mouse Induced by High-Fat Diet
- (2018) Jing-hua Peng et al. Frontiers in Pharmacology
- Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease
- (2017) Cheng Chen et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease
- (2017) Qin Feng et al. Oncotarget
- Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease
- (2017) Jin-Seok Byun et al. Biomed Research International
- Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
- (2016) Yaron Rotman et al. GUT
- Geniposide acutely stimulates insulin secretion in pancreatic β-cells by regulating GLP-1 receptor/cAMP signaling and ion channels
- (2016) Yi Zhang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice
- (2015) Ahmed Bettaieb et al. GASTROENTEROLOGY
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- Qushi Huayu Decoction Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein KinaseIn VivoandIn Vitro
- (2013) Qin Feng et al. Evidence-based Complementary and Alternative Medicine
- Aging promotes the development of diet-induced murine steatohepatitis but not steatosis
- (2012) Luis Fontana et al. HEPATOLOGY
- Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production
- (2012) Annie-Carole Tosello-Trampont et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of Kupffer cells in the morphogenesis of nonalcoholic steatohepatitis – ultrastructural findings. The first report in pediatric patients
- (2012) Joanna Maria Lotowska et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis
- (2011) Jeffrey W. Molloy et al. HEPATOLOGY
- Kupffer cells promote hepatic steatosis via interleukin-1β-dependent suppression of peroxisome proliferator-activated receptor α activity
- (2009) Rinke Stienstra et al. HEPATOLOGY
- Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
- (2008) Fabio Marra et al. TRENDS IN MOLECULAR MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started